NVCR

NASD NovoCure Ltd.

Nov 3, 2026 · 7:29 AM ET LAST TRADE Market Closed

$13.25 ↑ +0.04 (+0.30%) Trading Up from the previous close of $13.21

YTD change: +2.47%
vs 20-day SMA: -8.11%
vs 200-day SMA: -10.55%

Price ranges

Previous day

$13.08 $13.67

open $13.33 close $13.21

-$0.12 (-0.90%)

Today

$0.00 $0.00

$13.25

Past week

$11.85 $14.74

from $14.40 now $13.25

-$1.15 (-7.99%)

Past month

$11.85 $16.09

from $15.20 now $13.25

-$1.95 (-12.83%)

This year

$9.82 $21.45

from $12.93 now $13.25

+$0.32 (+2.47%)

Price & Performance

-3.72 (-21.97%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good

The stock is 94.3% away from all-time highs of $232.76
NVCR is up 2% since the beginning of the year
NVCR is up 8% over the past 12 months
NVCR is down 13% over the past 1 month
12% of all NVCR investors are betting against NVCR

NVCR reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +8.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.09

Earnings momentum +59.3% Quarterly EPS growth

Quarterly change +59.3%

Valuation

P/E ratio N/A

Enterprise value $1.3B

Beta 2.25

Balance sheet & scale

IncomeN/A

Revenue$725.4M

Cash$473.6M

Debt$231.6K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $1.5B

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, the United Kingdom.

Competitor comparison

Ticker	Company	Price	Change
CSLLY	CSL Limited Sponsored ADR	$35.35	-0.11%
ARGX	argenx SE Sponsored ADR	$874.97	-2.00%
ONC	BeOne Medicines Ltd. Sponsored ADR	$361.27	-2.45%
INCY	Incyte Corporation	$120.04	-0.29%
WXIBF	Wuxi Biologics (Cayman) Inc.	$5.69	+0.00%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.